John Lambert, Executive Vice President at ImmunoGen, and Seema Kumar, Principal Scientist at Pfizer & more to speak at GTCBio's Protein Discovery Summit.
Kevin Morris, City of Hope, to discuss "Genomic Dark Matter; The Complexities of Non-Coding RNA from Mechanism to Therapeutics" at Non-Coding RNA & RNAi Conference.
Marcus Carr, Vice President at Pfizer, will give a keynote presentation on, "Clinical Development of Gene Therapy for Hemophilia B" at 3rd Cell & Gene Therapy.
Hua Xu, Worldwide Medicinal Chemistry at Pfizer, to discuss "Chemical Biology Tools for Target Identification" at 11th Drug Design & Medicinal Chemistry Mtg.
John Schneekloth Jr., Principal Investigator at the National Cancer Institute, will give a presentation at GTCbio's 11th Drug Design & Medicinal Chemistry.
TJ Cradick, Head of Genome Editing at CRISPR Therapeutics, to talk on, "Therapeutic Gene Editing with CRISPR/CAS9" at 3rd Cell & Gene Therapy Conference.
Erin Keaney, Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a presentation at 11th Drug Design & Medicinal Chemistry.
Judy Lieberman, Professor of Pediatrics at Harvard Medical School, will give a keynote presentation at GTCbio's 7th Non-Coding RNA & RNAi Therapeutics Conference.
Diana Colleluori at Bluebird Bio will discuss, "Quality Control Considerations for Commercialization of Autologous Cell Products" at 3rd Cell & Gene Therapy conference.
Mark Trusheim, MIT to present, "Implementing Precision Medicine, Determining Economic Value under Adaptive Biomedical Innovation Pathways" at the Inaugural Precision Medicine Conference.
Paraskevi Giannakakou, Professor of Pharmacology in Medicine & Principal Investigator at Weill-Cornell Medical College, will give a presentation on, "Drug-Target Engagement in CTCs: From Mechanism to Clinical Application in Prostate Cancer" at GTCbio's 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA.
Robert Weinberg, MIT, will give a presentation, on "Mechanisms of Malignant Progression of Carcinomas" at 2nd Cancer Markers & Liquid Biopsies Conference.
GTCbio's Infectious Diseases World Summit is approaching quickly next month; with signups for the event closing soon, GTCBio is extending a last chance discount for delegates before registration closes.
Stefan Knapp at University of Oxford will discuss, "Design Strategies for the Development of Selective Kinase Inhibitors" at GTCbio's Med Chem Conference.
Stefan Knapp at University of Oxford will discuss, "Design Strategies for the Development of Selective Kinase Inhibitors" at GTCbio's Kinase Inhibitors Conf.
Johan Skog, CSO at Exosomes Diagnostics, will give a presentation on the current progress in exosome applications at GTCbio's 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA.
Rebecca Leary, Research Investigator III, Oncology Research at Novartis Institutes for Biomedical Research, will give a presentation on, "Characterizing the Cancer Genome from the Circulation" at GTCbio's 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA.
Helmy Eltoukhy, Co-Founder & Chief Executive Officer of Guardant Health, will give a keynote presentation on, "From Wired to Wireless: The Guardant Experience with 20,000+ Clinical Liquid Biopsies" at GTCbio's 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA.
Harvard's Michael Seaman talk is entitled "Choosing Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Infection".
Roderick Hubbard at Vernalis will discuss, "Strategies and Outcomes for Fragments for Kinases" at GTCbio's Kinase Inhibitors Design & Screening Conference.
Robert Webster of St. Jude will discuss "The Continuing Threat of H2N2, H5N1, H7N9 and H9N2 Influenza Viruses: Unmet Needs" at GTCbio's Vaccines R&D Meeting.
Robert Webster of St. Jude will discuss "The Continuing Threat of H2N2, H5N1, H7N9 and H9N2 Influenza Viruses: Unmet Needs" at GTCbio's Antiviral Drugs Meeting.
Jeffery Schloss, Ph.D., NHGRI to discuss "Developing Technologies for the $1,000 Genome-the Path to Today & Beyond" at GTCbio's 6th Next Generation Sequencing.
Nicholas Jackson, Sanofi Pasteur will discuss, "Zika Virus: Knowledge Gaps and Vaccine Research and Development Challenges" at GTCbio's Antiviral Drugs Meeting.
Nicholas Jackson, Sanofi Pasteur will discuss, "Zika Virus: Knowledge Gaps and Vaccine Research and Development Challenges" at GTCbio's Vaccines R&D Meeting.
John Doench, Associate Director, Genetic Perturbation Platform, Broad Institute of MIT and Harvard, to speak at GTCbio's CRISPR & Genome Engineering Conference.
Mark Albrecht, BARDA, to present "Expanding Public-Private Partnerships to Strengthen the Antimicrobial Pipeline" at Anti-Infectives Partnering & Deal-Making.
Randall Kincaid, of NIH to present "Development of Rapid Diagnostics to address Drug Resistance" at GTCbio's 2nd Bugs & Drugs: Antibacterial Drug Discovery.
Aristidis Veves, Professor of Surgery at Beth Israel Deaconess Medical Center will speak on "Novel Therapeutic Targets & Strategies for Diabetic Foot Ulceration and Peripheral Neuropathy" at GTCbio's 2016 Diabetes Summit.
Dennis France, Vice President of Research & Development, Horizon Discovery will speak on "Functional Genomics using CRISPR-Cas9 for the Identification & Validation of Novel Oncology Targets" at GTCbio's CRISPR & Genome Engineering Conference.
George Church at Harvard Medical School will discuss, "New Technologies for Collecting and Interpreting Petabytes for BRAIN and Precision Medicine projects" at GTCbio's Big Data Bioinformatics conference.
Katherine High will discuss Spark Therapeutics' Phase 3 trial for RPE65-mediated inherited retinal dystrophy at GTCbio's Ocular Diseases Drug Discovery Meeting.
Sheng Lin‐Gibson, at the National Institute of Standards and Technology of the Federal Agency, will give a presentation at GTCbio's Stem Cell Summit 2016.
Susan Taylor, Professor at UCSD will speak on "Dynamic Assembly and Regulation of Protein Kinases: Spines, Scaffolds and Catalysts" at 11th Protein Kinases in Drug Discovery Conference.
Jared Cumming, Director, Global Chemistry at Merck, will give a distinguished speaker presentation on, "Discovery of Verubecestat (MK-8931): A beta-Secretase Inhibitor in Phase 3 Clinical Development for Alzheimer's Disease" at GTCbio's 2nd Protease Inhibitors in Drug Discovery Conference to be held on March 1-2, 2016 in San Diego, CA.
Tomi Sawyer, Distinguished Scientist & Head of Peptide Drug Discovery & Innovative Technologies at Merck will keynote present at 2nd Protein-Protein Interaction Conference to be held on October 23-24, 2014 in Boston, MA by GTC.
Arthur Weiss, Ephraim P. Engleman Distinguished Professor at University of California San Francisco will give a keynote presentation on, "Controlling T Cell Receptor Signaling with Genetically Selective Kinase Inhibitors" at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA) by GTCbio.
Scot Mente, Senior Principal Scientist, Neuroscience Chemistry at Pfizer Research will give a presentation on, "Structure-Guided Design of CNS-Active CK1d Preferring Ligands" at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA) by GTCbio.
Juhi Juneja, Senior Research Investigator at Bristol-Myers Squibb to Speak at 2nd Protein-Protein Interaction Conference, October 23-24, 2014 in Boston, MA.
Mark Bunnage, Vice President, Head of Chemistry Biotherapeutics Research at Pfizer To Give a Keynote Presentation at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA).
Ricardo Henriques, University College London, to Speak on Super-Resolution Microscopy at Cell Based Assay & Screening Technologies Conference, October 7-8, 2014 in Dublin, Ireland.
Jianxin Zhang, Deputy Director of Protein Characterization at Sanofi Pasteur, will give a presentation on, "Antigen-Antibody Interaction Analyzed by Hydrogen-Deuterium Exchange Mass Spectrometry" at the 2nd Protein-Protein Interaction Conference to be held on October 23-24, 2014 in Boston, MA by GTCbio.
Nathanael Gray, Professor, Biological Chemistry and Molecular Pharmacology, Dana Farber Cancer Institute, Harvard Medical School To Give a Featured Presentation at the 3rd Protein Kinases & Drug Design Conference (Oct 23-24, 2014 in Boston, MA).
Igor Kaltashov, Professor and Graduate Program Director of Chemistry at the University of Massachusetts-Amherst to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA.
Frank Pacholec, Vice President, R&D & Corporate Sustainability Officer at Stepan Co. to Give Keynote Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (September 18-19, 2014 in San Francisco, CA).
Panel Discussion on, "Strategic Partnerships" Features Executives from Dow, Akzonobel, and Genomatica at 5th Biobased Chemicals Commercialization & Partnering Conference (September 18-19, 2014 in San Francisco, CA).
Vasilis Ntziachristos, Helmholtz Zentrum München, to Give Keynote Address at Imaging in Drug Discovery Conference, October 7-8, 2014 in Dublin, Ireland.
Dale Steichen, AkzoNobel to Give Keynote Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (September 18-19, 2014 in San Francisco, CA).
William Baum, Executive Chairman and Chief Business Development Officer of Genomatica to Give Featured Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (Sep 18-19, 2014 in San Francisco, CA).
Markus Pompejus, Vice President of White Biotechnology Research at BASF will give a keynote presentation at the 5th Biobased Chemicals Commercialization & Partnering Conference to be held on Sep. 18-19, 2014 in San Francisco, CA.
Aaron K Soto, Vice President of Research at Sutro Biopharma, to Give a Presentation titled, "Design and Manufacture of Homogeneous Best-in-Class Antibody Drug Conjugates and Bispecifics by Cell-Free Protein Expression" at the Protein Expression, Purification & Characterization Conference, October 23 & 24, 2014, in Boston, MA, by GTCbio.
James C. Errey, Associate Director at Heptares Therapeutics Limited to Give a Presentation titled, "From StaR® to Structure, it's as easy as ABC" at the Protein Expression, Purification & Characterization Conference, October 23 & 24, 2014, in Boston, MA.
John Herrmann, Chief Science Officer of Global External Research & Development, Oncology at Eli Lilly To Give a Keynote Presentation on "Partnering with Lilly Oncology: Current Priorities, NYC Innovation Hub Model & Possible Future States" at the Novel Cancer Therapeutics Summit 2014 to be held on July 7-8, 2014, in Boston, MA. This summit includes two parallel conferences focused on both the research, and business perspectives in oncology.
Mitchell Ho, Chief of the Antibody Therapy Section of the National Cancer Institute to give a presentation titled, "Development of Therapeutic Antibodies Targeting Glypican-3 in Liver Cancer" at the Antibody and Protein Therapeutics Conference, October 23 & 24, 2014, in Boston, MA by GTCbio.
Stephen Anderson, Director of Protein Chemistry at Sanofi Pasteur, Research and Development North America, to Give a Presentation titled, "A Three-Antibody Cocktail with Enhanced Potency and Breadth Against Nosocomial Disease" at the Antibody and Protein Therapeutics Conference, October 23 & 24, 2014, in Boston, MA, by GTCbio.
Marcia Haigis, Associate Professor, Department of Cell Biology at Harvard Medical School, To Keynote Present at the 5th Cancer Targets & Therapeutics Conference (July 7-8, 2014, in Boston, MA).
Panel Discussion on "Value Maximization vs. Capital Efficiency" Features Executives from AbbVie, Celgene, Johnson & Johnson, and Sofinnova Ventures at the 3rd Oncology Partnering & Deal-Making Conference (July 7-8, 2014, in Boston, MA).
Philippe Lopes-Fernandes, Senior Vice President of Global Licensing, Business Development & Alliance Management at Merck Serono, To Give a Keynote Presentation at the 3rd Oncology Partnering & Deal-Making Conference (July 7-8, 2014, in Boston, MA).
Richard Fisher, CSO of NeuroPhage Pharmaceutical, to Speak at 8th Neurodegenerative Conditions Research & Development Conference, Sept. 18-19, 2014 in San Francisco.
Owen Fields, Vice President of Regulatory Strategy for Pfizer Worldwide Research and Development, to Give a Presentation titled "Regulatory Development Issues and Solutions for Combination and Bifunctional Biologics" at the Antibody and Protein Therapeutics Conference, October 23 & 24, 2014 in Boston, MA by GTCBio.
David Merberg at Takeda Pharmaceuticals to Give a Presentation at the Bioinformatics & Pharmacogenomics: Managing and Analyzing Big Data Conference (Jun 19-20, 2014 in San Diego, CA).
John Herrmann, Chief Scientific Officer of Global External R&D, Oncology at Eli Lilly To Give Keynote Presentation at the 3rd Oncology Partnering & Deal-Making Conference (July 7-8, 2014 in Boston, MA).
Terry Gaasterland, Professor of Computational Biology and Genomics at the University of California, San Diego to Give a Presentation at the Bioinformatics & Pharmacogenomics: Managing and Analyzing Big Data Conference (Jun 19-20, 2014 in San Diego, CA).
Deepak Rajpal, Computational Biology Director at GlaxoSmithKline to Give a Featured Presentation at the Bioinformatics & Pharmacogenomics: Managing and Analyzing Big Data Conference (June 19-20, 2014 in San Diego, CA).
Paul Juniewicz, Head of Oncology Business Opportunities, Strategic Portfolio and Management Group at Sanofi, To Give a Keynote Presentation at the 3rd Oncology Partnering & Deal-making Conference (July 7-8, 2014 in Boston, MA).
Panel Discussion on "Innovative Partnering & Deal-making" Features Executives from Sanofi, Merck Serono, Johnson & Johnson, Novartis, AnaptysBio, and MedImmune at the 3rd Oncology Partnering & Deal-Making Conference (July 7-8, 2014 in Boston, MA).
Richard Beger, Director of the Biomarkers and Alternative Models Branch Division of Systems Biology at the National Center for Toxicological Research, FDA to give a keynote presentation on "Metabolomics of Acetaminophen Overdose in Rodents and Children" at the Metabolomics Conference - Advances & Applications in Human Disease to be held on May 22-23, 2014 in Cambridge, MA by GTC.
Steven F. Dowdy, Professor of Cellular and Molecular Medicine at the University of California, San Diego, School of Medicine, to give a presentation titled "Therapeutics: Bioreversible PhosphoTriester siRNN Prodrugs" at the Inaugural Nucleic Acid Research and Development Conference, June 19 & 20, 2014 in San Diego, CA.
Larry Gold, Chairman of the Board at SomaLogic, to give a presentation titled "Modern Aptamers: Exciting Applications in Life Sciences, Therapeutics, and Diagnostics" at the Inaugural Nucleic Acid Research and Development Conference, June 29 & 20, 2014 in San Diego, CA.
Robert Dunn, Professor of Chemistry at the Adams Institute of Bioanalytical Chemistry, University of Kansas, to give a presentation titled "Multiplexed Lable-Free Biosensing Using Whispering Gallery Mode Imaging" at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA by GTC.
Norman Dovichi, Grace-Rupley Professor at the University of Notre Dame, to give a presentation titled "Zone Electrophoresis-Mass Spectrometry at the zeptomole level," at the Inaugural Bioanalytical Sensors Conference, May 22 & 23, 2014 in Cambridge, MA.
Satisfied Users & 
Approved Press Releases
